12:52 EDT Hologic (HOLX) jumps 7%, halted after FT report on take private offer
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOLX:
- Hologic trading halted, volatility trading pause
- Hologic price target lowered to $70 from $77 at Stephens
- Hologic price target lowered to $65 from $77 at Morgan Stanley
- Hologic’s Hold Rating: Balancing Growth in Diagnostics with Challenges in Breast Health and Geopolitical Pressures
- Hologic’s Financial Outlook: Hold Rating Amid Revenue Decline and Tariff Challenges
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue